Checked
Beta Bionics, Inc.
Nasdaq: BBNX · Surgical & Medical Instruments & Apparatus · Irvine, CA
- Revenue
- $100.3M
- +53.9% vs. prior year
- Net income
- -$73.2M
- -73.0% net margin
- Total assets
- $328.7M
- Diluted EPS
- -$1.81
Company details
As reported to the SEC
- SEC CIK
- 1674632
- Stock
- Nasdaq: BBNX
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus (3841)
- Headquarters
- 11 Hughes, Irvine, CA 92618
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- , Emerging growth company
- Phone
- (949) 427-7785
- Employer ID (EIN)
- 47-5386878
- Last annual report
- 02/24/2026
- Last quarterly report
- 07/29/2026
Formerly: Beta Bionics, Inc (until 01/06/2025)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 |
|---|---|---|---|
| Revenue | $100.3M | $65.12M | $11.99M |
| Gross profit | $55.54M | $35.89M | $6.31M |
| Operating income | -$71.68M | -$45.25M | -$35.85M |
| Net income | -$73.2M | -$54.76M | -$44.1M |
| Diluted earnings per share | -$1.81 | -$8.60 | -$8.31 |
| Research and development | $34.79M | $26.18M | $17.94M |
| Total assets | $328.7M | $149.6M | $110M |
| Total liabilities | $41.13M | $73.63M | $51.43M |
| Shareholders' equity | $287.6M | -$245.4M | -$203.1M |
| Cash and cash equivalents | $31.58M | $30.43M | $26.57M |
| Cash from operations | -$50.92M | -$48.27M | -$32.45M |
| Capital expenditures | $5.3M | $3.4M | $402K |
Federal and state records filed under the name Beta Bionics, Inc.
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
FDA recalls
Recalls of food, drugs and devices reported to the FDA
Swipe the table sideways to see more columns.
| Product | Class | Started |
|---|---|---|
| iLet Bionic Pancreas, REF: BB1001 | Class II | 03/12/2026 |
| iLet Bionic Pancreas, REF: BB1001 | Class II | 09/23/2025 |
| iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software | Class II | 08/13/2025 |
Recent filings
56 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
97 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Beta Bionics, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other surgical & medical instruments & apparatus
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Medline Inc.MDLN | Northfield, IL | $28.43B | $1.16B |
| Stryker CorpSYK | Portage, MI | $25.12B | $3.25B |
| 3m CoMMM | St Paul, MN | $24.95B | $3.25B |
| Becton Dickinson & CoBDX | Franklin Lakes, NJ | $21.84B | $1.68B |
| Boston Scientific CorpBSX | Marlborough, MA | $20.07B | $2.89B |
| Baxter International IncBAX | Deerfield, IL | $11.24B | -$957M |
| Solventum CorpSOLV | Eagan, MN | $8.32B | $1.56B |
| Resmed IncRMD | San Diego, CA | $5.65B | $1.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Beta Bionics, Inc.'s CIK number?
- Beta Bionics, Inc.'s SEC Central Index Key (CIK) is 1674632.
- What is Beta Bionics, Inc.'s stock ticker?
- Beta Bionics, Inc. trades as Nasdaq: BBNX.
- What was Beta Bionics, Inc.'s revenue?
- Beta Bionics, Inc. reported revenue of $100.3M for the fiscal year ended Dec 31, 2025, +53.9% from the year before.
- When does Beta Bionics, Inc.'s fiscal year end?
- Beta Bionics, Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Beta Bionics, Inc. headquartered?
- Beta Bionics, Inc.'s principal executive office on file with the SEC is in Irvine, CA.
- Has Beta Bionics, Inc. had any FDA recalls?
- The FDA lists 3 recalls with Beta Bionics, Inc. as the recalling firm. The latest started Mar 12, 2026.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026